Raed Al-Rajabi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Raed Al-Rajabi

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Molecular Carcinogenesis|October 11, 2022

Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinomaDavid Standing, Levi Arnold, Prasad Dandawate, et al.

JAMA Oncology|April 21, 2022

Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell TransplantQamar J Khan, Cory R Bivona, Grace A Martin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A Shah, Kei Muro, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Molecular Carcinogenesis|October 11, 2022

Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinomaDavid Standing, Levi Arnold, Prasad Dandawate, et al.

JAMA Oncology|April 21, 2022

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A Shah, Kei Muro, et al.

Pageof 3